VALBIOTIS (EPA:ALVAL) Valbiotis announces the launch of a capital increase with the cancellation of preferential subscription rights with the introduction of a priority period for a gross amount of €15.0M secured by subscription agreements of up to 91.7% of its gross am
Transparency directive : regulatory news
12/12/2023 16:55